Asia-Pacific Cancer Vaccines Market Size Report 2023

Posted by rohan on August 21st, 2018

Asia-Pacific Cancer Vaccines Market was worth USD 0.63 billion in 2018 and estimated to reach USD 1.46 billion by the end of 2023 with a growing potential of 18.24 %. A cancer vaccine is a vaccine that either treats existing cancer or avoids advancement of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. A number of the vaccines are "autologous", being made from tests taken from the patient, and are particular to that patient. A few analysts guarantee that cancerous cells routinely emerge and are pulverized by the immune system and that tumors form when the immune system neglects to kill them.

Get a comprehensive overview of the Asia-Pacific Cancer Vaccines Market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/

Asia-Pacific Cancer Vaccines Market: Segmentation

By Cancer Type

•          Prostate
•          Cervical
•          Anal
•          Throat
•          Other cancers

Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/request-sample

By Vaccine Type

• Protein and Peptide based
• Tumour cell
• Dendritic cell
• Genetic vaccines
• Other Vaccines

By End Users

• Cancer Treatment Centres
• Research Institutes

Major players influencing the Asia-Pacific cancer vaccines market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian  Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx,  OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen and Vaxon Biotech.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com